Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer

BACKGROUND: The aromatase inhibitor anastrozole inhibits estrogen synthesis. Fulvestrant binds and accelerates degradation of estrogen receptors. We hypothesized that these two agents in combination might be more effective than anastrozole alone in patients with hormone-receptor (HR)–positive metast...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mehta, Rita S., Barlow, William E., Albain, Kathy S., Vandenberg, Ted A., Dakhil, Shaker R., Tirumali, Nagendra R., Lew, Danika L., Hayes, Daniel F., Gralow, Julie R., Livingston, Robert B., Hortobagyi, Gabriel N.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951300/
https://ncbi.nlm.nih.gov/pubmed/22853014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1201622
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares